Overexpression of inducible nitric oxide synthase and accumulation of 8-OHdG in nasopharyngeal carcinoma

Histopathology

Volumn 52, Issue 2, 2008, Pages 213-223

  Segawa, Y ^a   Oda, Y ^a   Yamamoto, H ^a   Uryu, H ^b   Shiratsuchi, H ^a   Hirakawa, N ^a   Tomita, K ^b   Yamamoto, T ^b   Oda, S ^b   Yamada, T ^a   Komune, S ^a   Tsuneyoshi, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

8 OHdG; iNOS; Nasopharyngeal carcinoma; Oxidative stress; p53

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; INDUCIBLE NITRIC OXIDE SYNTHASE; LATENT MEMBRANE PROTEIN 1; MESSENGER RNA; PROTEIN P53;

ADULT; AGED; ARTICLE; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; DEOXYGUANOSINE; DNA DAMAGE; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MUTATION; NASOPHARYNGEAL NEOPLASMS; NEOPLASMS, SQUAMOUS CELL; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RNA, MESSENGER; RNA, VIRAL; TUMOR SUPPRESSOR PROTEIN P53;

HUMAN HERPESVIRUS 4;

EID: 37549060680     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02920.x     Document Type: Article

References (53)

1. Chan JKC, Bray F, McCarron P et al. Nasopharyngeal carcinoma. In Barnes L, Eveson JW, Reichart P, Sidransky D, eds. WHO Classification of Tumours: Pathology and Genetics: Head and Neck Tumours. Lyon : IARC Press, 2005 85 97.
2. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin. Cancer Biol. 2002 12 431 441.
3. Yu MC, Garabrant DH, Huang TB et al. Occupational and other non-dietary risk factors for nasopharyngeal carcinoma in Guangzhou, China. Int. J. Cancer 1990 45 1033 1039.
4. Armstrong RW, Imrey PB, Lye MS, Armstrong MJ, Yu MC, Sani S. Nasopharyngeal carcinoma in Malaysian Chinese: occupational exposures to particles, formaldehyde and heat. Int. J. Epidemiol. 2000 29 991 998.
5. Hildesheim A, Dosemeci M, Chan CC et al. Occupational exposure to wood, formaldehyde, and solvents and risk of nasopharyngeal carcinoma. Cancer Epidemiol. Biomarkers Prev. 2001 10 1145 1153.
6. Majano PL, Garcia-Monzon C, Lopez-Cabrera M et al. Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. J. Clin. Invest. 1998 101 1343 1352.
7. Schweyer S, Mihm S, Radzun HJ, Hartmann H, Fayyazi A. Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection. Gut 2000 46 255 259.
8. Brunet LR, Beall M, Dunne DW, Pearce EJ. Nitric oxide and the Th2 response combine to prevent severe hepatic damage during Schistosoma mansoni infection. J. Immunol. 1999 163 4976 4984.
9. Ohshima H, Bandaletova TY, Brouet I et al. Increased nitrosamine and nitrate biosynthesis mediated by nitric oxide synthase induced in hamsters infected with liver fluke (Opisthorchis viverrini). Carcinogenesis 1994 15 271 275.
10. Tatemichi M, Ogura T, Nagata H, Esumi H. Enhanced expression of inducible nitric oxide synthase in chronic gastritis with intestinal metaplasia. J. Clin. Gastroenterol. 1998 27 240 245.
11. Wheeler MA, Smith SD, Garcia-Cardena G, Nathan CF, Weiss RM, Sessa WC. Bacterial infection induces nitric oxide synthase in human neutrophils. J. Clin. Invest. 1997 99 110 116.
12. Tanaka S, Choe N, Hemenway DR, Zhu S, Matalon S, Kagan E. Asbestos inhalation induces reactive nitrogen species and nitrotyrosine formation in the lungs and pleura of the rat. J. Clin. Invest. 1998 102 445 454.
13. Dizdaroglu M. Oxidative damage to DNA in mammalian chromatin. Mutat. Res. 1992 275 331 342.
14. Grollman AP, Moriya M. Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet. 1993 9 246 249.
15. Soo R, Putti T, Tao Q, Goh BC, Lee KH, Kwok-Seng L. Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression. Arch. Otolaryngol. Head Neck Surg. 2005 131 147 152.
16. Jayasurya A, Dheen ST, Yap WM, Tan NG, Ng YK, Bay BH. Inducible nitric oxide synthase and bcl-2 expression in nasopharyngeal cancer: correlation with outcome of patients after radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2003 56 837 845.
17. Yu JS, Tsai HC, Wu CC et al. Induction of inducible nitric oxide synthase by Epstein-Barr virus B95-8-derived LMP1 in Balb/3T3 cells promotes stress-induced cell death and impairs LMP1-mediated transformation. Oncogene 2002 21 8047 8061.
18. Horikawa T, Sheen TS, Takeshita H, Sato H, Furukawa M, Yoshizaki T. Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma. Am. J. Pathol. 2001 159 27 33.
19. Kitano H, Kitanishi T, Nakanishi Y et al. Expression of inducible nitric oxide synthase in human thyroid papillary carcinomas. Thyroid 1999 9 113 117.
20. Kondo S, Toyokuni S, Iwasa Y et al. Persistent oxidative stress in human colorectal carcinoma, but not in adenoma. Free Radic. Biol. Med. 1999 27 401 410.
21. Shinokuma A, Hirakawa N, Tamiya S, Oda Y, Komiyama S, Tsuneyoshi M. Evaluation of Epstein-Barr virus infection in sinonasal small round cell tumors. J. Cancer Res. Clin. Oncol. 2000 126 12 18.
22. Gallo O, Schiavone N, Papucci L et al. Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma. Am. J. Pathol. 2003 163 723 732.
23. Seki S, Kitada T, Sakaguchi H, Nakatani K, Wakasa K. Pathological significance of oxidative cellular damage in human alcoholic liver disease. Histopathology 2003 42 365 371.
24. Seki S, Kitada T, Yamada T et al. Immunohistochemical detection of 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, in human chronic cholecystitis. Histopathology 2002 40 531 535.
25. Yamamoto H, Kohashi K, Oda Y et al. Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene. Pathol. Int. 2006 56 584 590.
26. Ikeguchi M, Ueta T, Yamane Y, Hirooka Y, Kaibara N. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. Clin. Cancer Res. 2002 8 3131 3136.
27. Kobayashi C, Oda Y, Takahira T et al. Aberrant expression of CHFR in malignant peripheral nerve sheath tumors. Mod. Pathol. 2006 19 524 532.
28. Oda Y, Sakamoto A, Satio T, Kawauchi S, Iwamoto Y, Tsuneyoshi M. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma. Mod. Pathol. 2000 13 994 1004.
29. Tschugguel W, Schneeberger C, Unfried G et al. Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade. Breast Cancer Res. Treat. 1999 56 145 151.
30. Tanaka H, Kijima H, Tokunaga T et al. Frequent expression of inducible nitric oxide synthase in esophageal squamous cell carcinomas. Int. J. Oncol. 1999 14 1069 1073.
31. Liu CY, Wang CH, Chen TC, Lin HC, Yu CT, Kuo HP. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. Br. J. Cancer 1998 78 534 541.
32. Ambs S, Merriam WG, Bennett WP et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 1998 58 334 341.
33. Klotz T, Bloch W, Volberg C, Engelmann U, Addicks K. Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer 1998 82 1897 1903.
34. Gallo O, Masini E, Morbidelli L et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J. Natl Cancer Inst. 1998 90 587 596.
35. Loft S, Moller P. Oxidative DNA damage and human cancer: need for cohort studies. Antioxid. Redox Signal. 2006 8 1021 1031.
36. Kohno T, Shinmura K, Tosaka M et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanin in damaged DNA. Oncogene 1998 16 3219 3225.
37. Jaiswal M, LaRusso NF, Nishioka N, Nakabeppu Y, Gores GJ. Human Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide. Cancer Res. 2001 61 6388 6393.
38. Cho EY, Hildesheim A, Chen CJ et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol. Biomarkers Prev. 2003 12 1100 1104.
39. Geller DA, Nussler AK, Di Silvio M et al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 1993 90 522 526.
40. Puhakka AR, Harju TH, Paakko PK, Soini YM, Kinnula VL. Nitric oxide synthases are associated with bronchial dysplasia. Lung Cancer 2006 51 275 282.
41. Anazawa T, Dimayuga PC, Li H et al. Effect of exposure to cigarette smoke on carotid artery intimal thickening: the role of inducible NO synthase. Arterioscler. Thromb. Vasc. Biol. 2004 24 1652 1658.
42. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991 51 6304 6311.
43. Forrester K, Ambs S, Lupold SE et al. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc. Natl. Acad. Sci. U.S.A. 1996 93 2442 2447.
44. Ambs S, Bennett WP, Merriam WG et al. Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J. Natl Cancer Inst. 1999 91 86 88.
45. Fujimoto H, Sasaki J, Matsumoto M et al. Significant correlation of nitric oxide synthase activity and p53 gene mutation in stage I lung adenocarcinoma. Jpn. J. Cancer Res. 1998 89 696 702.
46. Murata J, Tada M, Iggo RD, Sawamura Y, Shinohe Y, Abe H. Nitric oxide as a carcinogen: analysis by yeast functional assay of inactivating p53 mutations induced by nitric oxide. Mutat. Res. 1997 379 211 218.
47. Routledge MN. Mutations induced by reactive nitrogen oxide species in the supF forward mutation assay. Mutat. Res. 2000 450 95 105.
48. Wink DA, Kasprzak KS, Maragos CM et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991 254 1001 1003.
49. Chen CN, Hsieh FJ, Cheng YM, Chang KJ, Lee PH. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer. J. Surg. Oncol. 2006 94 226 233.
50. Zhang J, Peng B, Chen X. Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin. Cancer Res. 2005 11 7334 7343.
51. Maki A, Kono H, Gupta M et al. Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma. Ann. Surg. Oncol. 2007 14 1182 1190.
52. Miyake H, Hara I, Kamidono S, Eto H. Prognostic significance of oxidative DNA damage evaluated by 8-hydroxy-2′-deoxyguanosine in patients undergoing radical nephrectomy for renal cell carcinoma. Urology 2004 64 1057 1061.
53. Shang ZJ, Li ZB, Li JR. In vitro effects of nitric oxide synthase inhibitor L-NAME on oral squamous cell carcinoma: a preliminary study. Int. J. Oral Maxillofac. Surg. 2006 35 539 554.